在一个长期护理机构的COVID-19反应,用于患者
Luisa Delazer1,2,3, Noah Pressler4, Simona Balestrini1,2,5
1Chalfont Centre for Epilepsy, Chalfont St Peter, Bucks, UK.
Epilepsia open
|April 9, 2024
概括
长期护理中的患者有高无症状SARS-CoV-2感染率,与他们的医疗保健工作者不同. 这项研究突出了他们在疫情期间的弹性和低严重性结果.
科学领域:
- 神经学 神经学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 长期护理设施是传染病爆发的高风险环境.
- 理解SARS-CoV-2 (COVID-19) 在患者等脆弱人群中的感染动态至关重要.
研究的目的:
- 评估无症状的SARS-CoV-2感染率和患者居民及其医护人员的严重程度.
- 为了比较长期护理机构内居民和工作人员之间的感染特征.
主要方法:
- 每周的SARS-CoV-2 PCR监测测试从2020年4月到2022年6月进行.
- 症状数据是通过居民和医护人员的问卷收集的.
- 医疗记录提供了人口统计信息,并发症和发作频率.
主要成果:
- 62%的居民 (55/89) 至少有一次检测出SARS-CoV-2阳性; 37% (20/55) 无症状.
- 只有6% (4/63) 的健康工作者检测阳性无症状.
- 在一个单独的疫苗接种研究中,卫生保健工作者显示有17%的无症状感染 (7/41).
结论:
- 与医疗保健工作者相比,患有的居民表现出无症状SARS-CoV-2感染率显著更高.
- 尽管无症状率很高,但居民经历了低严重程度和致命的结果,这表明弹性.
- 在SARS-CoV-2感染期间或之后没有观察到对发作频率的影响.
更多相关视频
09:16Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
Published on: June 21, 2019
25.6K
08:43Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System
Published on: July 21, 2015
25.6K
相关概念视频
Arteries of the Lower Limbs
188
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
188
Seizures: Classification
339
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
339
Electroconvulsive Therapy
39
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
39
Antiepileptic Drugs: Glutamate Antagonists
325
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
325
Antiepileptic Drugs: Potassium Channel Activators
176
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
176
Antiepileptic Drugs: GABAergic Pathway Potentiators
388
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
388
